The ministry said that obtaining the vaccine was free for all citizens and expatriates in order to implement the Kingdom’s wise leadership guidelines, the Saudi Gazette reported.
The ministry confirmed the vaccine’s safety and efficacy after successfully going through the vaccine testing phases, and the successful tests demonstrated its strong immune response and antibodies in those who received experimental shots.
The ministry stated that vaccination will be carried out in three phases and that each phase has target groups. The first phase will cover citizens and expatriates over 65 years of age. Health workers and other professionals most susceptible to infection during their fight against the pandemic; People who are obese with a body mass index (BMI) over 40.
This would also include those who suffer from immunodeficiency, such as B. those who have had an organ transplant or are taking immunosuppressants; People who have two or more of the following chronic diseases: asthma, diabetes, chronic kidney disease, chronic heart disease, including coronary artery disease and chronic obstructive pulmonary disease, and anyone with a history of stroke.
The target group in the second phase are citizens and expatriates who are older than 50 years; the remaining naturopaths and those suffering from any of the following chronic diseases: asthma, diabetes, chronic kidney disease, chronic heart disease including coronary artery disease, chronic obstructive pulmonary disease, and active cancer, as well as those who are obese and have a BMI between 30 and 40.
The target group in the third phase includes all citizens and expatriates who want to receive the vaccine.
The Ministry of Health indicated that this move is a continuation of the great effort and proactive steps the Kingdom has taken since the outbreak of the pandemic and that it has an important role in containing the spread of the pandemic and in protecting health and health plays security for citizens and expatriates.
The ministry drew attention to the UK’s earlier announcement that it will be one of the first countries to receive vaccines that meet the criteria for efficacy and safety, directly from leading international vaccine industry companies and through COVAX, a global initiative The aim is to work with vaccine manufacturers.
There are 172 countries and several vaccine candidates involved in the Global Access Facility for Covid-19 vaccines.